Tofogliflozin attenuates liver steatosis and fibrosis in non-diabetic non-alcoholic steatohepatitis mice. Ozono Y, Kawakami H, Hatada H, Uchiyama N, et al. BMC Gastroenterol 2026 Jan 15. doi: 10.1186/s12876-026-04610.

Read + Share

Amedeo Smart

Independent Medical Education

Ozono Y, Kawakami H, Hatada H, Uchiyama N, et al. Tofogliflozin attenuates liver steatosis and fibrosis in non-diabetic non-alcoholic steatohepatitis mice. BMC Gastroenterol 2026 Jan 15. doi: 10.1186/s12876-026-04610.
PMID: 41540395